Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NMDP

New Results Show Donor Search Prognosis Score Equalizes Transplant Outcomes at American Society of Hematology Annual Meeting 2024
From NMDP
Via Business Wire
NMDP℠ Raises $1.1 Million at Annual Gala Expanding Access to Life-Saving Cell Therapies
From NMDP
Via GlobeNewswire
NMDP℠ Organizes Nationwide Fundraisers to Propel Research, Aid Patients with Blood Cancer and Diseases
From NMDP
Via GlobeNewswire
NMDP Named ‘Best Place to Work’ Fourth Year in a Row
From NMDP
Via GlobeNewswire
NMDP℠ Raises More Than $235,000 at Annual LA Gala Fundraiser
From NMDP
Via GlobeNewswire
Journal of Clinical Oncology Publishes Study Finding No Discernable Difference in Overall Survival or GVHD-free-Relapse Free Survival for Mismatched Unrelated Adult Donors Versus Matched Unrelated Donors
From NMDP
Via Business Wire
NMDP Hires New Leaders to Executive Team to Continue Advancing Five-Year Strategic Plan
From NMDP
Via Business Wire
NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
From NMDP
Via Business Wire
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Saving Cell Therapy
From NMDP
Via GlobeNewswire
NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting
From NMDP
Via GlobeNewswire
NMDP Cycle Kicks Off Nationwide Cycling Events Giving Hope to Patients in Need of a Blood Stem Cell Transplant
From NMDP
Via GlobeNewswire
NMDP Receives Record-Breaking $5 Million Philanthropic Gift
From NMDP
Via GlobeNewswire
NMDP Awards 25th Annual ‘Amy Scholars’ Grant, Furthering Post-Transplant Research
From NMDP
Via GlobeNewswire
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
From NMDP
Via GlobeNewswire
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
From NMDP
Via GlobeNewswire
Be The Match® Affirms Global Leadership in Life-saving Cell Therapies with New Name, Brand: NMDP℠
From NMDP
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.